Seropositivities to human papillomavirus types 16, 18, or 33 capsids and to Chlamydia trachomatis are markers of sexual behavior

Journal of Infectious Diseases

Volumn 173, Issue 6, 1996, Pages 1394-1398

  Dillner, Joakim ^a   Kallings, Ingcgerd ^b   Brihmer, Christina ^b   Sikström, Bo ^b   Koskcla, Pentti ^b   Lehtinen, Matti ^b   Schiller, John T ^b   Sapp, Martin ^b   Mårdh, Per Anders ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SEROEPIDEMIOLOGY; SEXUAL BEHAVIOR; SWEDEN; VIRUS CAPSID; VIRUS TRANSMISSION; VIRUS TYPING; WART VIRUS;

EID: 0029801205     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/173.6.1394     Document Type: Article

References (31)

1. Koutsky L, Holmes KK, Critchlow CW, et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 1992;327:1272-8.
2. Schiffman MH, Bauer HM, Hoover RN, et al. Epidemiological evidence that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Nail Cancer Inst 1993; 85:958-63.
3. Pontén J, Adami HO, Bergström R, et al. Strategies for global control of cervical cancer. Int J Cancer 1995; 60:1-26.
4. Ley C, Bauer HM, Reingold A, et al. Determinants of genital human papillomavirus infection in young women. J Natl Cancer Inst 1991;83: 997-1003.
5. Bauer HM, Ting Y, Greer CE, et al. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 1991;265:472-7.
6. Hildeshcim A, Gravitt P, Schiffman MH, et al. Determinants of genital human papillomavirus infection in low-income women in Washington, DC. Sex Transm Dis 1993;20:279-85.
7. Fredericks BD, Balkin A, Daniel HW, Schonrock J, Ward B, Frazer IH. Transmission of human papillomaviruses from mother to child. Aust NZ J Obstet Gynaecol 1993;33:30-2.
8. Pakarian F, Kaye J, Cascn J, et al. Cancer associated human papillomaviruses: perinatal transmission and persistence. Br J Obstet Gynaecol 1994;101:514-7.
9. Jenison SA, Yu XP, Valentine JM, et al. Evidence of prevalent genital-type human papillomavirus infections in adults and children. J Infect Dis 1990; 162:60-9.
10. Pao CC, Tsai PL, Chang YL, Hsieh TT, Jin JY. Non-sexual papillomavirus transmission routes. Lancet 1992;339:1479-80.
11. Rylander E, Ruusuvaara L, Wiksten-Almstromer M, Evander M, Wadell G. The absence of vaginal HPV-16 DMA in women with no experience of sexual intercourse. Obstet Gynecol 1994; 83:534-6.
12. Fairley CK, Chen S, Tabrizi SN, Leeton K, Quinn MA, Garland SM. The absence of genital human papillomavirus DNA in virginal women. Int J STD AIDS 1992;3:414-7.
13. Andersson-Ellström A, Hagmar B, Johansson B, Kalantari M, Wärleby B, Forssman L. Human papillomavirus DNA in cervix only detected in girls after coitus. Int J STD AIDS (in press).
14. Jochmus-Kudielka I, Schneider A, Braun R, et al. Antibodies against the human papillomavirus type 16 early proteins in human sera: correlation of anti-E7 reactivity with cervical cancer. J Natl Cancer Inst 1989; 81 : 1698-704.
15. Mueller M, Viscidi RP, Ulken V, et al. Antibodies to the E4, E6, and E7 proteins of human papillomavirus type 16 in patients with HPV-associated diseases and in the normal population. J Invest Dermatol 1995; 104:138-41.
16. Dillner J. Serology of human papillomavirus. Cancer J 1995; 8:264-9.
17. Kirnbauer R, Taub J, Greenstone H, et al. Efficient self-assembly of human papillomavirus type 16 Ll and L1-L2 into virus-like particles. J Virol 1993;67:6929-36.
18. Kirnbauer R, Hubbert NL, Wheeler CM, Decker TM, Lowy DR, Schiller JT. A virus-like particle ELISA detects serum antibodies in a majority of women infected with human papillomavirus type 16. J Natl Cancer Inst 1994;86:494-8.
19. Wikström A, Van Doornum GJJ, Quint WGV, Schiller JT, Dillner J. Identification of human papillomavirus seroconversions. J Gen Virol 1995;76:529-39.
20. Andersson-Ellström A, Dillner J, Hagmar B, Schiller J, Forssman L. No serological evidence for non-sexual spread of HPV-I6 [letter]. Lancet 1994;344:1435.
21. Andersson-Ellström A, Dillner J, Hagmar B, et al. Comparison of development of serum antibodies to HPV-16 and HPV-33 and acquisition of cervical HPV DNA among sexually experienced and virginal young girls. A longitudinal cohort study. Sex Transm Dis (in press).
22. Volpers C, Schirmacher P, Streeck RE, Sapp M. Assembly of the major and minor capsid proteins of HPV type 33 into virus-like particles and tubular structures in insect cells. Virology 1994;200:504-12.
23. Cowan FM, Johnson AM, Ashley R, Corey L, Mindel A. Antibody to herpes simplex virus type 2 as serological marker of sexual lifestyle in populations. Br Med J 1994;309:1325-9.
24. Hanna L, Keshismyan H. Chlamydial antigens stabilized with formalin for use in the micro-immunofluorescence test. J Clin Microbiol 1980; 12:409-14.
25. Dillner J, Wiklund F, Lenner P, et al. Antibodies against linear and conformational epitopes of human papillomavirus type 16 that independently associate strongly with cervical cancer. Int J Cancer 1995;60:377-82.
26. Heino P, Eklund C, Fredriksson-Shahnazarian V, Goldman S, Schiller JT, Dillner J. Association of serum IgG antibodies against human papillomavirus type 16 capsids with anal epidermoid carcinoma. J Natl Cancer Inst 1995; 87:437-40.
27. Syrjänen K, Syrjänen S. Epidemiology of human papilloma virus infections and genital neoplasia. Scand J Infect Dis 1990;69:7-17.
28. Eliezri YD, Silverstein SJ, Nuovo GJ. The occurrence of human papillomavirus DNA in cutaneous squamous and basal cell neoplasms. J Am Acad Dermatol 1990;23:836-42.
29. Togawa K, Jaskiewicz K, Takahashi H, Meltzer SJ, Rustgi AK. Human papillomavirus DNA sequences in esophagus squamous cell carcinoma. Gastroenterology 1994; 107:128-36.
30. Franco EL, Villa LL, Ruiz A, Costa MC. Transmission of cervical human papillomavirus infection by sexual activity: differences between low and high oncogenic risk types. J Infect Dis 1995; 172:756-63.
31. Schiffman MH. Recent progress in defining the epidemiology of human papillomavirus infection and cervical neoplasia. J Natl Cancer Inst 1992; 84:394-8.